MOESM1 of Visual biofeedback training reduces quantitative drugs index scores associated with fall risk

Additional file 1. Sheet 1: Mod Pre Med Data: includes a list of drugs for participants prior to the study with Quantitative Drug Index (QDI) scores under each drug. Total QDI score for each participant is in column AJ, and total drug counts for each participant is in column AK. Sheet 2: Mod Post Med Data: includes a list of drugs for participants at the end of the study with Quantitative Drug Index (QDI) scores under each drug. Total QDI score for each participant is in column AD, and total drug counts for each participant is in column AE. Sheet 3: Pre & Post data: columns for each variable are as described: total pre-study QDI drug score (Mod Pre Drug Score) for each participant, total post-study QDI drug score (Mod Post Drug Score) for each participant, change in QDI scores (dQDI) post-intervention minus pre-intervention, whether participants (Group) were in the control arm (treadmill walking onlyâ 0) or the intervention arm (gait training plus visual biofeedbackâ 1); age, height, weight, participant stated number of falls in the previous 12Â months (fall 12 prev months), Mini-Mental State Exam scores (MMSE), pre-study Activity Specific Balance Confidence scale scores (Pre ABCscore) and post-study Activity Specific Balance Confidence scale scores (Post ABCscore).

附加文件1。
工作表1：用药前标准化数据（Mod Pre Med Data）：收录受试者入组研究前的用药清单，每种药物下方均标注有定量药物指数（Quantitative Drug Index, QDI）评分。每位受试者的总QDI评分位于AJ列，总用药计数位于AK列。
工作表2：用药后标准化数据（Mod Post Med Data）：收录受试者研究终点时的用药清单，每种药物下方均标注有定量药物指数（QDI）评分。每位受试者的总QDI评分位于AD列，总用药计数位于AE列。
工作表3：前后对照数据：各变量列说明如下：每位受试者的研究前总QDI药物评分（Mod Pre Drug Score）、研究后总QDI药物评分（Mod Post Drug Score）、干预后与干预前的QDI评分差值（dQDI，即干预后评分减去干预前评分）、受试者所属组别（Group）：对照组（仅开展跑步机行走，标记为0）或干预组（实施步态训练联合视觉生物反馈，标记为1）；年龄、身高、体重、受试者自述的既往12个月跌倒次数、简易精神状态检查量表（Mini-Mental State Exam, MMSE）评分、研究前特异性活动平衡信心量表（Activity Specific Balance Confidence scale, ABC）评分（Pre ABCscore）以及研究后该量表评分（Post ABCscore）。